您的位置: 首页 > 2015年11月 第46卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

阿司匹林在房颤抗凝治疗中的弱化

The limitations of aspirin for anticoagulation in atrial fibrillation

来源期刊: 广州医药 | 90-91 发布时间:2021-11-30 收稿时间:2025/11/13 16:40:09 阅读量:20
作者:
关键词:
阿司匹林心房颤动抗凝治疗
AspirinAtrial fibrillationAnticoagulant therapy
DOI:
10.3969/j.issn.1000-8535.2015.06.034
收稿时间:
2015-07-22 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 研讨阿司匹林广泛用于高危血栓、栓塞抗凝的预防治疗应用。方法 查阅参考文献,结合临床实践,新口服抗凝药疗效终点卒中和体循环栓塞方面为基准。结果 界於CHADS2和CHA2DS2-VASc 评分所涵盖的风险和差异因素,后期华法林与新口服抗凝药可能取舍或并存。结论 在危险分层,卒中抗拴防凝治疗中,我国房颤患者不建议继续服用阿司匹林。
Objective To Study and discuss the applications for prevention and treatment of high risky thrombosis and embolism anticoagulation of Aspirin. Methods Combining literature consultation and clinical practice,making stroke and general circulation embolism of oral anticoagulant curative effect terminal point as the base. Results According to the risky and different factors covered by CHADS2 and CHA2DS2-VASc in the later stage, warfarin and the new oral anticoagulant can be taken together or abandon one of them. Conclusion In the risky factors classification and stroke anticoagulant therapy, we suggest that the atrial fibrillation patients should not take Aspirin.
1、 Hart RG, Pearce LA, Aguilar MI. Meta-analysis:antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J]. Ann Intern Med,2007(146):857-867. Hart RG, Pearce LA, Aguilar MI. Meta-analysis:antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J]. Ann Intern Med,2007(146):857-867.
2、 李晓红,董建增,马长生.口服抗凝药物与停药反跳[J]. 中华内科杂志,2014,53(2):147-148. 李晓红,董建增,马长生.口服抗凝药物与停药反跳[J]. 中华内科杂志,2014,53(2):147-148.
3、 国家药典委员会编.临床用药须知化学药和生物制品卷[M]. 北京:中国医药科技出版社,2011:968. 国家药典委员会编.临床用药须知化学药和生物制品卷[M]. 北京:中国医药科技出版社,2011:968.
4、 国家药典委员会编.临床用药须知化学药和生物制品卷[M]. 人民卫生出版社,2005:698 国家药典委员会编.临床用药须知化学药和生物制品卷[M]. 人民卫生出版社,2005:698
5、 葛均波 徐永健主编.内科学[M]. 8版.人民卫生出版社,2013:189. 葛均波 徐永健主编.内科学[M]. 8版.人民卫生出版社,2013:189.
6、 中国国家处方集编委会.中国国家处方集化学药品与生物制品卷[M]. 北京:人民军医出版社,2011:195. 中国国家处方集编委会.中国国家处方集化学药品与生物制品卷[M]. 北京:人民军医出版社,2011:195.
7、 朱俊,胡大一.关于我国非瓣膜病心房颤动血栓栓塞危险评分意见[J]. 中华心血管病杂志,2013;41(3):181-182. 朱俊,胡大一.关于我国非瓣膜病心房颤动血栓栓塞危险评分意见[J]. 中华心血管病杂志,2013;41(3):181-182.
8、 Tse HF, Wang YJ, Ahmed Ai-Abdullah M,et al, Stroke Prevention in atrial fibrillation-an Asian stroke perspective[J]. Heatt Rhythm, 2013(10):1082-1088. Tse HF, Wang YJ, Ahmed Ai-Abdullah M,et al, Stroke Prevention in atrial fibrillation-an Asian stroke perspective[J]. Heatt Rhythm, 2013(10):1082-1088.
9、 相艳敏、颜红兵,朱俊,等.解读美国心脏协会/美国心脏病学学会/心律学会最新心房颤动治疗指南[J]. 中华心血管病杂志,2014,42(11):971. 相艳敏、颜红兵,朱俊,等.解读美国心脏协会/美国心脏病学学会/心律学会最新心房颤动治疗指南[J]. 中华心血管病杂志,2014,42(11):971.
10、 Camm AJ, Lip Gy De, Caterina R,et al. 2012 focused update of the ESC Guidelines for the management of atrial fihrillation:an update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association[J]. Eur Heart J,2012(33):2719-2747. Camm AJ, Lip Gy De, Caterina R,et al. 2012 focused update of the ESC Guidelines for the management of atrial fihrillation:an update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association[J]. Eur Heart J,2012(33):2719-2747.
11、 January Ct, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:areport of the American College of Cardiology/American heart Association task force on practice guidelines and the Heart Rhythm Society[J/OL],J AmCollCardiol,2014[2014-04-16].pii:S0735-1097(14)01740-9. January Ct, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:areport of the American College of Cardiology/American heart Association task force on practice guidelines and the Heart Rhythm Society[J/OL],J AmCollCardiol,2014[2014-04-16].pii:S0735-1097(14)01740-9.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录